Vaccine therapy in the treatment of melanoma.
Maguire
H C
HC
Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107.
D000951:Antigens, Neoplasm / Q000008:administration & dosage; D005732:Gangliosides / Q000008:administration & dosage; D006801:Humans; D016233:Immunotherapy, Active; D008545:Melanoma / Q000276:immunology / Q000556:secondary / Q000628:therapy*; D058950:Melanoma-Specific Antigens; D009163:Mycobacterium bovis; D009363:Neoplasm Proteins / Q000008:administration & dosage; D012074:Remission Induction; D012878:Skin Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*
D000951:Antigens, Neoplasm; D005732:Gangliosides; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins; C049132:9-O-acetyl-GD3 ganglioside